GlassScriptPhysician profile
Ronald D Menard
NPI 1699760520
$856.72
in general payments reported to CMS, 2019-2025
11 companies · $16.28 in 2025
The $16.28 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $198 · 2022: $137 · 2023: $452 · 2024: $53.65 · 2025: $16.28.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $521.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $521.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $169.25 | 2023 | Puraply |
| Paratek Pharmaceuticals, INC. | $136.34 | 2023 | Nuzyra |
| Bioventus LLC | $123.65 | 2022 | |
| Janssen Pharmaceuticals, INC | $110.00 | 2019 | |
| Convatec INC. | $86.98 | 2023-2024 | |
| Allergan, INC. | $69.22 | 2019 | |
| Bard Peripheral Vascular, INC. | $62.33 | 2023 | Venclose Maven Catheter |
| Abbvie INC. | $41.77 | 2022-2023 | |
| Solventum Corporation | $22.34 | 2024 | Activ.A.C. |
| Neos Therapeutics, LP | $18.56 | 2019 | |
| Smith+Nephew, INC. | $16.28 | 2025 | Collagenase Santyl |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Menard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.